The many facets of SDF-1α, CXCR4 agonists and antagonists on hematopoietic progenitor cells

被引:50
作者
Faber, Anne
Roderburg, Christoph
Wein, Frederik
Saffrich, Rainer
Seckinger, Anja
Horsch, Kerstin
Diehlmann, Anke
Wong, Donald
Bridger, Gary
Eckstein, Volker
Ho, Anthony D.
Wagner, Wolfgang
机构
[1] Univ Heidelberg, Dept Med5, D-69120 Heidelberg, Germany
[2] Chemokine Therapeut Corp, Vancouver, BC V6T 1Z3, Canada
[3] AnorMED Inc, Langley, BC V2Y 1N5, Canada
[4] Univ Heidelberg, Dept Physiol & Pathophysiol, D-69120 Heidelberg, Germany
来源
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY | 2007年
关键词
D O I
10.1155/2007/26065
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Stromal cell-derived factor-1alpha (SDF-1 alpha) has pleiotropic effects on hematopoietic progenitor cells (HPCs). We have monitored podia formation, migration, proliferation, and cell-cell adhesion of human HPC under the influence of SDF-1 alpha, a peptide agonist of CXCR4 (CTCE-0214), a peptide antagonist (CTCE-9908), and a nonpeptide antagonist (AMD3100). Whereas SDF-1 alpha induced migration of CD34+ cells in a dose-dependent manner, CTCE-0214, CTCE-9908, and AMD3100 did not induce chemotaxis in this concentration range albeit the peptides CTCE-0214 and CTCE-9908 increased podia formation. Cell-cell adhesion of HPC to human mesenchymal stromal cells was impaired by the addition of SDF-1 alpha, CTCE-0214, and AMD3100. Proliferation was not affected by SDF-1 alpha or its analogs. Surface antigen detection of CXCR4 was reduced upon treatment with SDF-1 alpha or AMD3100 and it was enhanced by CTCE-9908. Despite the fact that all these molecules target the same CXCR4 receptor, CXCR4 agonists and antagonists have selective effects on different functions of the natural molecule.
引用
收藏
页数:10
相关论文
共 56 条
[11]   Potential clinical applications of the CXCR4 antagonist bicyclam AMD3100 [J].
De Clercq, E .
MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2005, 5 (09) :805-824
[12]  
De La Luz SM, 2004, BLOOD, V103, P2452, DOI [10.1182/blood-2003-08-2857, DOI 10.1182/BL00D-2003-08-2857]
[13]   Endolyn (CD164) modulates the CXCL12-mediated migration of umbilical cord blood CD133+ cells [J].
Forde, Sinead ;
Tye, Britt Jorgensen ;
Newey, Sarah E. ;
Roubelakis, Maria ;
Smythe, Jon ;
McGuckin, Colin P. ;
Pettengell, Ruth ;
Watt, Suzanne M. .
BLOOD, 2007, 109 (05) :1825-1833
[14]   The fleet feet of haematopoietic stem cells: rapid motility, interaction and proteopodia [J].
Frimberger, AE ;
McAuliffe, CI ;
Werme, KA ;
Tuft, RA ;
Fogarty, KE ;
Benoit, BO ;
Dooner, MS ;
Quesenberry, PJ .
BRITISH JOURNAL OF HAEMATOLOGY, 2001, 112 (03) :644-654
[15]  
Fruehauf S, 2002, J LEUKOCYTE BIOL, V71, P425
[16]   The CXCR4 antagonist AMD3100 releases a subset of G-CSF-primed peripheral blood progenitor cells with specific gene expression characteristics [J].
Fruehauf, Stefan ;
Seeger, Timon ;
Maier, Patrick ;
Li, Li ;
Weinhardt, Stephan ;
Laufs, Stephanie ;
Wagner, Wolfgang ;
Eckstein, Volker ;
Bridger, Gary ;
Calandra, Gary ;
Wenz, Frederick ;
Zeller, W. Jens ;
Goldschmidt, Hartmut ;
Ho, Anthony D. .
EXPERIMENTAL HEMATOLOGY, 2006, 34 (08) :1052-1059
[17]   CAMP-induced PKCζ activation increases functional CXCR4 expression on human CD34+ hematopoietic progenitors [J].
Goichberg, P ;
Kalinkovich, A ;
Borodovsky, N ;
Tesio, M ;
Petit, I ;
Nagler, A ;
Hardan, I ;
Lapidot, T .
BLOOD, 2006, 107 (03) :870-879
[18]   Mutations at the CXCR4 interaction sites for AMD3100 influence anti-CXCR4 antibody binding and HIV-1 entry [J].
Hatse, S ;
Princen, K ;
Vermeire, K ;
Gerlach, LO ;
Rosenkilde, MM ;
Schwartz, TW ;
Bridger, G ;
De Clercq, E ;
Schols, D .
FEBS LETTERS, 2003, 546 (2-3) :300-306
[19]   Plasma elevation of stromal cell-derived factor-1 induces mobilization of mature and immature hematopoietic progenitor and stem cells [J].
Hattori, K ;
Heissig, B ;
Tashiro, K ;
Honjo, T ;
Tateno, M ;
Shieh, JH ;
Hackett, NR ;
Quitoriano, MS ;
Crystal, RG ;
Rafii, S ;
Moore, MAS .
BLOOD, 2001, 97 (11) :3354-3360
[20]  
Holloway W, 1999, CYTOMETRY, V37, P171, DOI 10.1002/(SICI)1097-0320(19991101)37:3<171::AID-CYTO2>3.0.CO